AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliptiwak M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Hanuchem Laboratories

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Gliptiwak M 500mg/50mg Tablet

Metformin/Sitagliptin 500mg/50mg tablets manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Prescription may be standalone or adjunctive to other antidiabetic therapies. Optimal efficacy necessitates a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose readings, and concurrent medications. Ingesting with food minimizes gastrointestinal distress. Consistent daily administration ensures maximum therapeutic benefit; cessation requires physician approval. Maintaining glycemic control prevents future complications. Adherence to your doctor's dietary and exercise plan is crucial for effective diabetes management; lifestyle significantly influences disease control. Common adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Concurrent use with insulin or sulfonylureas increases hypoglycemia risk; learn its recognition and management. This medication isn't universally suitable. Inform your doctor about pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting. Pregnant or lactating individuals require medical consultation. Potential drug interactions necessitate disclosure of all medications to ensure treatment safety. Alcohol should be limited due to its hypoglycemic effects. Your physician will monitor renal function and glucose levels throughout treatment.

Uses of Gliptiwak M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Gliptiwak M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 500mg/50mg Gliptiwak M tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Gliptiwak M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Gliptiwak M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Gliptiwak M 500mg/50mg tablets should be administered with a meal.

How Gliptiwak M 500mg/50mg Tablet works:

Metformin and Glimepiride 500mg/50mg tablets (Gliptiwak M) offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Gliptiwak M 500mg/50mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Gliptiwak M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Gliptiwak M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by abnormally high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliptiwak M 500mg/50mg tablets cautiously. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Gliptiwak M 500mg/50mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Gliptiwak M 500mg/50mg Tablet :

Should you forget a Gliptiwak M 500mg/50mg Tablet dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliptiwak M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliptiwak M 500mg/50mg Tablet

Gliptiwak M 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate calorie intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. These symptoms are more likely if you skip meals, consume alcohol, overexert yourself, or take other diabetes medications concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Gliptiwak M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Gliptiwak M 500mg/50mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Gliptiwak M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin, both anti-diabetic medications. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Gliptiwak M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Gliptiwak M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged Gliptiwak M 500mg/50mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia and neurological issues.
Gliptiwak M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea). Report any persistent side effects to your doctor.
Gliptiwak M 500mg/50mg Ta...
78
MRP 90
13% off